Greenberg Traurig (GT) is a proud sponsor of ACI's 29th Annual ACI Drug & Medical Device Litigation Conference -- the premier event for the Products Liability and MDL Defense Bar, taking place December 3-4 in New York City, New York.
This conference allows 400+ pharmaceutical and device litigators, private practice attorneys and Judges to network and discuss the latest multi-district litigation strategies. This year, the conference will cover the impact of new MDL case management changes, navigating the new Rule 702 amendments, the benefits and risks of utilizing bankruptcy as a mass tort resolution vehicle, litigation exit strategies, and much more. Content-rich program and sophisticated panel discussions will provide attendees with real-world insights on the most critical international developments impacting drug and device product liability litigation.
On December 3, Lori Cohen will deliver keynote remarks, Marcella Ducca will speak on the panel titled, “Countering Plaintiff Strategies: Overcoming Expanded Liability Tactics," and Greg Ostfeld will speak on the panel titled, "From Nuclear Verdicts to Thermonuclear Verdicts: Evaluating the True Impact on Drug and Medical Device Manufacturers." Allison Ng and Steve Harkins will also deliver opening remarks during the GT-sponsored luncheon. GT is co-hosting the ACI Drug & Medical Device Reception taking place at R Lounge in Times Square.
More information can be found here: https://www.americanconference.com/drug-medical-device-litigation/